Business Micro
News Stories
Odisha Steps Up Urban Development Drive with Focus on Clean Cities and Better Civic Services
Bhubaneswar, Aug 24: The Odisha government has reiterated its focus on building cleaner, safer and better-planned cities while improving housing,…
Read MoreNovotech Strengthens Presence in Japan with Opening of Tokyo Office
Business Wire India Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in…
Read MoreNew US$22 Million Education Lifeline for Crisis-Affected Children in Sudan
New three-year investment will reach nearly 200,000 crisis-affected children and adolescents, helping them return to safe, inclusive learning while supporting…
Read MoreIBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open
NEW YORK, Aug. 24, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the United States Tennis Association (USTA) today announced new…
Read MorePhilanthropy Activates Campus-Wide Opportunities
Aug 24: With its new innovative pledges for student readiness and experiential learning, renowned distinction in teaching and research, and…
Read MoreFDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
Business Wire India Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued…
Read MoreFrom Forecasts to Foresight: CROSSDIVE 2026 to Examine India’s Next Decade
Business Wire India Pune will host CROSSDIVE 2026, Global Foresight Summit, on 22–23 October, bringing together Indian and international foresight…
Read MorePrestige Misty Waters – Vista Tower Wins Award at 220th Lalbagh Horticultural Exhibition
Bengaluru, Aug 24: Prestige Misty Waters – Vista Tower, an apartment complex in Kempapura, Hebbal has won the award for…
Read MoreIndia and Mauritius Move to Deepen Energy Partnership
Port Louis, August 24, 2026: India and Mauritius have taken fresh steps to strengthen bilateral cooperation in the energy sector,…
Read MoreAnbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 24, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company,…
Read More